Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 3rd:
Sarepta Therapeutics, Inc. (SRPT - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
Sarepta’s shares gained 11.7% over the last month compared with the S&P 500’s advance of 4.3%. The company possesses a Momentum Score of A.
Wingstop Inc. (WING - Free Report) : This restaurant franchise has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.
Wingstop’s shares gained 36.7% over the last three months compared with the S&P 500’s advance of 11.2%. The company possesses a Momentum Score of A.
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Regeneron’s shares gained 26.1% over the last six months compared with the S&P 500’s advance of 7%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Names #1 Semiconductor Stock
It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 3rd:
Sarepta Therapeutics, Inc. (SRPT - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.6% over the last 60 days.
Sarepta’s shares gained 11.7% over the last month compared with the S&P 500’s advance of 4.3%. The company possesses a Momentum Score of A.
Wingstop Inc. (WING - Free Report) : This restaurant franchise has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.
Wingstop’s shares gained 36.7% over the last three months compared with the S&P 500’s advance of 11.2%. The company possesses a Momentum Score of A.
Regeneron Pharmaceuticals, Inc. (REGN - Free Report) : This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Regeneron’s shares gained 26.1% over the last six months compared with the S&P 500’s advance of 7%. The company possesses a Momentum Score of A.
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks Names #1 Semiconductor Stock
It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Get the latest research report on REGN - FREE
Get the latest research report on SRPT - FREE
Get the latest research report on WING - FREE